CRISPR/Cas “non-target” sites inhibit on-target cutting rates
Eirik A. Moreb(Duke University), Michael Lynch(Duke University)
Cited by 4
Related Papers
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
|Science|2015|1.1k
Managing the SOS Response for Enhanced CRISPR-Cas-Based Recombineering in <i>E. coli</i> through Transient Inhibition of Host RecA Activity
|ACS Synthetic Biology|2017|60
Scalable, robust, high-throughput expression & purification of nanobodies enabled by 2-stage dynamic control
|Metabolic Engineering|2024|12
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
|Carolina Digital Repository (University of North Carolina at Chapel Hill)|2016|2